Kin-Cohort Analysis of LRRK2-G2019S Penetrance in Parkinson's Disease
June 2011
in “
Movement Disorders
”
Studysummary The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on movementdisorders.onlinelibrary.wiley.com →